Samsung Biologics Co.,Ltd.
207940
Classificação em ações
#498
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Preço da ação
$1,028.49
Valor de mercado
$47.88B
Variação (1 dia)
-3.67%
Variação (1 ano)
-18.37%
País
KR
Negociar Samsung Biologics Co.,Ltd. (207940)
Categoria
Healthcare
Receita da Samsung Biologics Co.,Ltd. (207940)
Receita em Sep 2026 TTM: $3.30B
De acordo com os últimos relatórios financeiros da Samsung Biologics Co.,Ltd., a receita atual da empresa (TTM) é $3.30B. Em 2024, a empresa obteve uma receita de $2.38B uma diminuição em relação a a receita do ano 2023, que foi de $2.85B. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Samsung Biologics Co.,Ltd. de 2014 a 2026
Receita no final de cada ano
| Ano | Receita | Alterar |
|---|---|---|
| 2026 (TTM) | $3.30B | 4.55% |
| 2025 | $3.15B | 32.61% |
| 2024 | $2.38B | -16.65% |
| 2023 | $2.85B | 20.00% |
| 2022 | $2.38B | 80.33% |
| 2021 | $1.32B | 22.93% |
| 2020 | $1.07B | 76.59% |
| 2019 | $607.57M | 26.26% |
| 2018 | $481.19M | 10.37% |
| 2017 | $435.96M | 78.42% |
| 2016 | $244.35M | 214.60% |
| 2015 | $77.67M | -19.17% |
| 2014 | $96.09M | 0.00% |
Receita de empresas similares ou concorrentes
| Empresa | Receita | Diferença de Receita | País |
|---|---|---|---|
| $12.62B | 282.80% |
US
|
|
| $2.23B | -32.44% |
US
|
|
| $15.74B | 377.41% |
AU
|
|
| $10.11B | 206.59% |
BE
|
|
| $6.02B | 82.58% |
NL
|
